98%
921
2 minutes
20
Background: This study aimed to evaluate the 4-week clinical efficacy of the lumbar sympathetic ganglion block (LSGB), assess the perfusion index (PI) as a marker for the LSGB's technical success, and examine the relationship between the PI change and post-procedure pain relief.
Methods: In this prospective observational study, pain scores of 40 patients who underwent LSGB were measured using the Numeric Rating Scale (NRS) at pre-procedure, 20 minutes post-procedure, and at 1 and 4 weeks. The primary outcome was a positive LSGB response, defined as a reduction of ≥ 2 on the NRS at 20 minutes post-procedure. Skin temperature and PI were recorded every minute for 20 minutes post-procedure. The reliability of the PI was assessed using area under the curve (AUC) and receiver operating characteristic curves.
Results: An immediate positive response to the LSGB was observed in 72.5% of patients, with 30.8% responding at 1 week and 17.9% responding at 4 weeks. NRS scores significantly decreased from baseline to 4.1 ± 2.5 immediately post-procedure and to 5.9 ± 2.7 at 4 weeks. A Δ PI of > 1.6% in the ipsilateral foot was a reliable indicator of technical success (sensitivity: 90.0%; specificity: 90.0%; AUC: 0.925; < 0.001). However, neither temperature increase (R = 0.091, = 0.577) nor PI increase (R = 0.029, = 0.859) correlated significantly with pain reduction.
Conclusions: Although the number of LSGB responders declined over 4 weeks, overall pain levels significantly decreased. The PI may serve as a quick and reliable indicator of technical success, but it does not correlate with post-procedure pain relief.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221961 | PMC |
http://dx.doi.org/10.3344/kjp.24373 | DOI Listing |
Cereb Cortex
August 2025
Statistical Parametric Mapping is a widely used package of software for brain image analysis. It has also been the vehicle for sustained theoretical innovation and global impact in cognitive neuroscience. What can we learn from its success as it reaches middle age?
View Article and Find Full Text PDFCereb Cortex
August 2025
Translational Neuromodeling Unit (TNU), Institute for Biomedical Engineering, University of Zurich & ETH Zurich, Zurich, Switzerland.
Statistical Parametric Mapping (SPM) is a statistical framework and open source software package for neuroimaging data analysis. Originally created by Karl Friston in the early 1990s, it has been used by a vast number of scientific studies over the last three decades. SPM has not only revolutionized the analysis of neuroimaging data but also catalyzed the development of cognitive neuroscience.
View Article and Find Full Text PDFMol Divers
September 2025
Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, Nanjing, 211198, China.
Drug absorption significantly influences pharmacokinetics. Accurately predicting human oral bioavailability (HOB) is essential for optimizing drug candidates and improving clinical success rates. The traditional method based on experiment is a common way to obtain HOB, but the experimental method is time-consuming and costly.
View Article and Find Full Text PDFJ Interv Card Electrophysiol
September 2025
Cardiac Ablation Solutions, Medtronic, Minneapolis, MN, USA.
Background: Catheter ablation is beneficial in patients with symptomatic persistent atrial fibrillation (PerAF), and pulsed field ablation (PFA) is a promising energy source to safely and durably create ablation lesions. However, catheter-specific "PFA waveforms and designs" result in effectiveness and safety profiles that are not transferable to other PFA technologies. A head-to-head comparison between the dual-energy, wide-footprint lattice-tip (Sphere-9, Medtronic) and pentaspline PFA catheter (Farawave, Boston Scientific) is not yet available.
View Article and Find Full Text PDFEmerg Radiol
September 2025
Monash Imaging, Monash Health, VIC, Clayton, Australia.
Purpose: To evaluate the efficacy and complications of absorbable haemostatic gelatin uterine artery embolisation for symptomatic acquired uterine arterio-venous malformation (UAVM).
Methods: All the adult female patients who had acute urogenital bleeding due to UAVM confirmed on ultrasound and received uterine artery embolisation (UAE) for UAVM in a tertiary institution between January 2000 and October 2024 were included. Patients who had UAE for other causes were excluded.